Literature DB >> 9268504

gamma-AChR/epsilon-AChR switch at agrin-induced postsynaptic-like apparatus in skeletal muscle.

M Rimer1, I Mathiesen, T Lømo, U J McMahan.   

Abstract

We transfected the extrajunctional region of denervated soleus muscles in adult rats with neural agrin cDNA to induce myofibers to form postsynaptic-like apparatus containing acetylcholine receptor (AChR) aggregates. By 1 week approximately 30% of the AChR aggregates contained a mixture of epsilon-AChRs and gamma-AChRs while approximately 70% had only gamma-AChRs. If the transfected muscles were reinnervated in the original junctional region, the postsynaptic-like apparatus, despite the absence of apposed axon terminals, gradually came to have only epsilon-AChRs. We conclude that at the postsynaptic apparatus of ectopic neuromuscular junctions formed by a foreign nerve implanted into the extra-junctional region of denervated muscles, agrin secreted by the axon terminal plays a direct role in the gamma-AChR/epsilon-AChR switch that occurs as the apparatus reaches maturity. Our findings, together with results from other studies, indicate further that agrin and acetylcholine are the only nerve-derived factors required for this switch.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268504     DOI: 10.1006/mcne.1997.0622

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

3.  Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering.

Authors:  A S Mohamed; K A Rivas-Plata; J R Kraas; S M Saleh; S L Swope
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

4.  Soluble miniagrin enhances contractile function of engineered skeletal muscle.

Authors:  Weining Bian; Nenad Bursac
Journal:  FASEB J       Date:  2011-11-10       Impact factor: 5.191

5.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

6.  Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease.

Authors:  Sophia Kapchinsky; Madhusudanarao Vuda; Kayla Miguez; Daren Elkrief; Angela R de Souza; Carolyn J Baglole; Sudhakar Aare; Norah J MacMillan; Jacinthe Baril; Paul Rozakis; Vita Sonjak; Charlotte Pion; Mylène Aubertin-Leheudre; Jose A Morais; R Thomas Jagoe; Jean Bourbeau; Tanja Taivassalo; Russell T Hepple
Journal:  J Physiol       Date:  2018-05-19       Impact factor: 5.182

7.  Electron microscopic structure of agrin and mapping of its binding site in laminin-1.

Authors:  A J Denzer; T Schulthess; C Fauser; B Schumacher; R A Kammerer; J Engel; M A Ruegg
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

8.  MuSK induces in vivo acetylcholine receptor clusters in a ligand-independent manner.

Authors:  A Sander; B A Hesser; V Witzemann
Journal:  J Cell Biol       Date:  2001-12-17       Impact factor: 10.539

9.  Effects of purified recombinant neural and muscle agrin on skeletal muscle fibers in vivo.

Authors:  G Bezakova; J P Helm; M Francolini; T Lømo
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

10.  Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins.

Authors:  T Meier; F Masciulli; C Moore; F Schoumacher; U Eppenberger; A J Denzer; G Jones; H R Brenner
Journal:  J Cell Biol       Date:  1998-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.